Ethics in the digital workplace
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
Catalent UK, the British subsidiary of the US-based global pharmaceutical company, has confirmed that it will close its plant in Bolton, Greater Manchester, in the north west of England, over the next nine months. The closure will make 150 jobs redundant, which will be relocated to the company sites in the US, Germany and Bathgate, Scotland.
A representative of the company said the decision about the planned closure was made after reviewing the demand for clinical trial supply services in the UK.
A representative of the trade union Unite said the closure was due to the UK leaving the European Union and added that the job loss was a ‘blow’ to the employees and the local economy.
Catalent develops and manufactures drugs, gene therapies and consumer health products. It employs more than 14,000 people globally. The company currently has five sites across England and Scotland, with the Bolton site specialising in clinical trial supplies.
Eurofound (2021), Catalent, Relocation in United Kingdom, factsheet number 103198, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/103198.